E-Mail
Annually, more than 350,000 children in the world are affected by pediatric cancer. Radiation has improved outcomes dramatically, but the damage caused to healthy tissue can affect the long-term health of a child. While clinicians and radiation specialists design treatments using the most up-to-date information available, there hasn t been a single guiding source of data to make evidence-based decisions that are specific for children. Now, a volunteer international research collaboration is working toward providing evidence-based guidelines for radiation therapy dosing for children. Results from this effort will help in minimizing side effects while continuing to provide effective radiation therapy.
An introduction to PENTEC or Pediatric Normal Tissue Effects in the Clinic was recently published in the
DGAP-News: Izotropic Corporation: Tomosynthese-Pionier tritt dem wissenschaftlichen Beirat von Izotropic bei
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DGAP-News: Tomosynthese-Pionier tritt dem wissenschaftlichen Beirat von Izotropic bei (deutsch) ()
aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.